Annual Meeting Archives
2016
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) Faculty of Pharmacy, University of Coimbra, Portugal
Category:
Transdermal Delivery
Institutions:
(1) Palo Alto Research Center Inc. (PARC), U.S.A.
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Sungkyunkwan University, Korea; (2) Sungkyunkwan University, India; (3) Hanyang University, Korea
Category:
Tissue Engineering
Institutions:
(1) University of Iowa, U.S.A.
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) The University of Queensland, Australia
Category:
Local Drug Delivery
Institutions:
(1) National University of Singapore, Singapore; (2) Institute of Bioengineering and Nanotechnology, Singapore
Category:
Ocular Drug Delivery
Institutions:
(1) U.S. FDA, U.S.A.
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) The catholic university of Korea, Korea
Category:
Taking Stock of Progress and Challenges in Drug Delivery and Targeting
Institutions:
(1) University of Helsinki, Finland; (2) University of California Davis, U.S.A.
Category:
Transdermal Delivery
Institutions:
(1) Dongguk University, South Korea; (2) Chung-Ang University, Korea; (3) NanoResource Co. Ltd, Korea; (4) Dongguk University, Korea
Category:
Transdermal Delivery
Institutions:
(1) UGC Centre of Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University,, India; (2) UGC Centre of Advanced Studies, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India, India; (3) U
Category:
Taking Stock of Progress and Challenges in Drug Delivery and Targeting
Institutions:
(1) University of Connecticut, U.S.A.; (2) University of Connecticut Health Center, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Vermont, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Biomedical Engineering Department, Yale University, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Biomedical Engineering Department, Yale University, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Graduate school of Engineering, Kyushu University, Japan
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) University of Illinois at Urbana-Champaign, U.S.A.
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Omeros, U.S.A.
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Monash Institute of Pharmaceutical Science, Australia; (2) University of New South Wales, Australia
Category:
Oral Delivery
Institutions:
(1) University of Nottingham, United Kingdom
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) University of Birmingham, United Kingdom
Category:
Oral Delivery
Institutions:
(1) Monash Institute of Pharmaceutical Sciences, Australia; (2) University of Copenhagen, Denmark; (3) Aradigm Corporation, U.S.A.; (4) Australian Synchrotron, Australia
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) US Food and Drug Administration, U.S.A.; (2) US FDA, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) UNIVERSITI KEBANGSAAN MALAYSIA, Malaysia
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) University of Iowa, U.S.A.